Literature DB >> 33891904

Interactions between Ligand-Bound EGFR and VEGFR2.

Michael D Paul1, Kalina Hristova2.   

Abstract

In this work, we put forward the provocative hypothesis that the active, ligand-bound RTK dimers from unrelated subfamilies can associate into heterooligomers with novel signaling properties. This hypothesis is based on a quantitative FRET study that monitors the interactions between EGFR and VEGFR2 in the plasma membrane of live cells in the absence of ligand, in the presence of either EGF or VEGF, and in the presence of both ligands. We show that direct interactions occur between EGFR and VEGFR2 in the absence of ligand and in the presence of the two cognate ligands. However, there are not significant heterointeractions between EGFR and VEGFR2 when only one of the ligands is present. Since RTK dimers and RTK oligomers are believed to signal differently, this finding suggests a novel mechanism for signal diversification.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  EGFR; VEGFR2; cell signaling; heterooligomers; receptor tyrosine kinases

Mesh:

Substances:

Year:  2021        PMID: 33891904      PMCID: PMC8173486          DOI: 10.1016/j.jmb.2021.167006

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   6.151


  64 in total

Review 1.  The ErbB signaling network: receptor heterodimerization in development and cancer.

Authors:  M A Olayioye; R M Neve; H A Lane; N E Hynes
Journal:  EMBO J       Date:  2000-07-03       Impact factor: 11.598

Review 2.  Targeting Eph receptors with peptides and small molecules: progress and challenges.

Authors:  Roberta Noberini; Ilaria Lamberto; Elena B Pasquale
Journal:  Semin Cell Dev Biol       Date:  2011-10-25       Impact factor: 7.727

Review 3.  Helix-helix interactions in membrane domains of bitopic proteins: Specificity and role of lipid environment.

Authors:  Eduard V Bocharov; Konstantin S Mineev; Konstantin V Pavlov; Sergey A Akimov; Andrey S Kuznetsov; Roman G Efremov; Alexander S Arseniev
Journal:  Biochim Biophys Acta Biomembr       Date:  2016-11-22       Impact factor: 3.747

Review 4.  Regulation of signal transduction and signal diversity by receptor oligomerization.

Authors:  M A Lemmon; J Schlessinger
Journal:  Trends Biochem Sci       Date:  1994-11       Impact factor: 13.807

5.  Spatial control of EGF receptor activation by reversible dimerization on living cells.

Authors:  Inhee Chung; Robert Akita; Richard Vandlen; Derek Toomre; Joseph Schlessinger; Ira Mellman
Journal:  Nature       Date:  2010-03-07       Impact factor: 49.962

Review 6.  The HER family and cancer: emerging molecular mechanisms and therapeutic targets.

Authors:  Natalia V Sergina; Mark M Moasser
Journal:  Trends Mol Med       Date:  2007-11-05       Impact factor: 11.951

7.  Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor.

Authors:  B I Terman; M Dougher-Vermazen; M E Carrion; D Dimitrov; D C Armellino; D Gospodarowicz; P Böhlen
Journal:  Biochem Biophys Res Commun       Date:  1992-09-30       Impact factor: 3.575

8.  Cooperation of neurotrophin receptor TrkB and Her2 in breast cancer cells facilitates brain metastases.

Authors:  Cecilia Choy; Khairul I Ansari; Josh Neman; Sarah Hsu; Matthew J Duenas; Hubert Li; Nagarajan Vaidehi; Rahul Jandial
Journal:  Breast Cancer Res       Date:  2017-04-26       Impact factor: 6.466

9.  A ROR1-HER3-lncRNA signalling axis modulates the Hippo-YAP pathway to regulate bone metastasis.

Authors:  Chunlai Li; Shouyu Wang; Zhen Xing; Aifu Lin; Ke Liang; Jian Song; Qingsong Hu; Jun Yao; Zhongyuan Chen; Peter K Park; David H Hawke; Jianwei Zhou; Yan Zhou; Shuxing Zhang; Han Liang; Mien-Chie Hung; Gary E Gallick; Leng Han; Chunru Lin; Liuqing Yang
Journal:  Nat Cell Biol       Date:  2017-01-23       Impact factor: 28.824

10.  A role for VEGF as a negative regulator of pericyte function and vessel maturation.

Authors:  Joshua I Greenberg; David J Shields; Samuel G Barillas; Lisette M Acevedo; Eric Murphy; Jianhua Huang; Lea Scheppke; Christian Stockmann; Randall S Johnson; Niren Angle; David A Cheresh
Journal:  Nature       Date:  2008-11-09       Impact factor: 49.962

View more
  1 in total

Review 1.  Recent progress on vascular endothelial growth factor receptor inhibitors with dual targeting capabilities for tumor therapy.

Authors:  Yun Liu; Yang Li; Yuxi Wang; Congcong Lin; Dan Zhang; Juncheng Chen; Liang Ouyang; Fengbo Wu; Jifa Zhang; Lei Chen
Journal:  J Hematol Oncol       Date:  2022-07-07       Impact factor: 23.168

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.